FindTrial
Sign In

Neostigmine/Glycopyrrolate

DRUG5 trials

Sponsors

Radboud University Medical Center, Northern Sydney Anaesthesia Research Institute, Temple University, Emory University, Matias Vested

Conditions

Anesthesia Recovery PeriodAppendicitisChronic Obstructive Pulmonary DiseaseNeuromuscular BlockadeNeuromuscular Blockade, ResidualPulmonary ComplicationsSurgery

Phase 4

Street Fitness in Surgical Patients Undergoing General Anesthesia After Reversal of Neuromuscular Blockade
NCT01453530
Radboud University Medical CenterAnesthesia Recovery Period
Start: 2011-10-31End: 2012-09-30Target: 30Updated: 2011-10-18
Prevention of Postoperative Events Following Reversal With Sugammadex or Neostigmine
TerminatedNCT02825576
Northern Sydney Anaesthesia Research InstitutePulmonary Complications
Start: 2018-12-03End: 2021-01-01Updated: 2023-03-29
Comparison of Time to Extubation Using Sugammadex or Neostigmine
CompletedNCT04606901
Temple UniversityChronic Obstructive Pulmonary Disease, Neuromuscular Blockade
Start: 2021-04-08End: 2023-07-30Updated: 2024-03-13
Sugammadex vs Neostigmine Reversal in Pediatric Appendectomy
TerminatedNCT05256901
Emory UniversityAppendicitis, Surgery
Start: 2023-07-19End: 2024-08-05Updated: 2025-09-30
Neostigmine/Glyco-pyrrolate 50 Mikrogram/kg or Sugammadex 2 mg/kg for Reversal of Neuromuscular Blockade in Elderly Patients
CompletedNCT06228092
Matias VestedNeuromuscular Blockade, Residual
Start: 2023-12-04End: 2025-05-04Updated: 2025-08-26

Related Papers

Neostigmine Versus Sugammadex for Reversal of Neuromuscular Blockade in Elderly Patients: A Blinded Randomised Study.
2026-01-01